MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $180,000 | -58.4% | 145,089 | +3.2% | 0.00% | -100.0% |
| Q1 2017 | $433,000 | -21.8% | 140,579 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $554,000 | -34.3% | 135,885 | +2.4% | 0.00% | -50.0% |
| Q3 2016 | $843,000 | +16.9% | 132,760 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $721,000 | -25.3% | 133,760 | +16.1% | 0.00% | -33.3% |
| Q1 2016 | $965,000 | +9.2% | 115,250 | +3.0% | 0.00% | 0.0% |
| Q4 2015 | $884,000 | +1.5% | 111,910 | +9.4% | 0.00% | 0.0% |
| Q3 2015 | $871,000 | -30.8% | 102,320 | +0.5% | 0.00% | -25.0% |
| Q2 2015 | $1,259,000 | +9.1% | 101,831 | +4.8% | 0.00% | +33.3% |
| Q1 2015 | $1,154,000 | +25.4% | 97,141 | +19.4% | 0.00% | 0.0% |
| Q4 2014 | $920,000 | +28.9% | 81,381 | +0.1% | 0.00% | +50.0% |
| Q3 2014 | $714,000 | +21.8% | 81,271 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $586,000 | +53.4% | 80,381 | +6.1% | 0.00% | +100.0% |
| Q1 2014 | $382,000 | -10.7% | 75,771 | -5.5% | 0.00% | 0.0% |
| Q4 2013 | $428,000 | +35.0% | 80,191 | -4.0% | 0.00% | 0.0% |
| Q3 2013 | $317,000 | -41.5% | 83,491 | +3.7% | 0.00% | -50.0% |
| Q2 2013 | $542,000 | – | 80,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|